HIGHLIGHTS OF PRESCRIBING INFORMATION 1
2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE MAXALT®and MAXALT-MLT®are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use MAXALT should only be used where a clear diagnosis of migraine has been established.If a patient
Actived: 1 days ago
HIGHLIGHTS OF PRESCRIBING INFORMATION
10-mg tablets are white to off-white, capsule-shaped tablets debossed with "414" on one side. 4 CONTRAINDICATIONS ZETIA is contraindicated in the following conditions: The combination of ZETIA with a statin is contraindicated in patients with active liver disease or unexplained persistent elevations in hepatic transaminase levels.